Review




Structured Review

ICON plc nonmem version 7.4
Nonmem Version 7.4, supplied by ICON plc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/approximated+classification+expectation-maximization+algorithm/nonmem+version+7+3/pm37503916-51-14-17
Average 90 stars, based on 1 article reviews
nonmem version 7.4 - by Bioz Stars, 2026-11
90/100 stars

Images

Related Articles

Clinical Proteomics:

Article Title: Effect of Amiodarone on Apixaban Exposure in Patients after Cardiac Surgery-A Population Pharmacokinetic Study.
Article Snippet: Aim To investigate the effect of amiodarone on apixaban pharmacokinetics in cardiac surgery patients with postoperative atrial fibrillation.. Methods Apixaban concentrations of postoperative cardiac surgery patients with or without amiodarone therapy were quantified using liquid chromatography–tandem mass spectrometry (LC–MS/MS) in clinical routine.. A population pharmacokinetic model was built using nonlinear mixed effects modeling in NONMEM® 7.5 using first-order conditional estimation with interaction.

Article Title: Population Pharmacokinetic Analysis of Enalapril and Enalaprilat in Newly Treated Children with Heart Failure: Implications for Safe Dosing of Enalapril (LENA Studies)
Article Snippet: PopPK analysis was performed by nonlinear mixed effects modelling using NONMEM ® version 7.2.0 (ICON plc, Dublin, Ireland) and Perl-speaks-NONMEM version 4.9.0 [ , ] via the graphical user interface Pirana ® version 2.9.6 (Certara, Radnor, PA, USA).

Article Title: Population pharmacokinetics and optimized dosing of cefuroxime in critically ill patients.
Article Snippet: Non-linear mixed-effect modelling was performed using NONMEM version 7.5.0 (Icon plc, Dublin, Ireland) with Pirana 2.9.7 (Certara, Princeton, NJ) as an interface using the first order conditional estimation with interaction (FOCE+I).

Article Title: Population Pharmacokinetic and Exposure-Response Analyses of Ibrutinib Combined With Bendamustine and Rituximab in Patients With Mantle Cell Lymphoma.
Article Snippet: Non- linear mixed effects modeling for the population PK analysis was performed using NONMEM version 7.3.0 (ICON plc, MD, USA) [17].

Article Title: Population Pharmacokinetic and Pharmacokinetic‐Pharmacodynamic Modeling of Serum M‐Protein Response for Modakafusp Alfa in a Phase 1/2 Study of Patients With Relapsed or Refractory Multiple Myeloma
Article Snippet: The population PK analysis for modakafusp alfa was conducted using NONMEM Version 7.4.4 (ICON plc, Dublin, Ireland) implementing the Monte Carlo importance sampling (IMP) with Laplacian conditional estimation method with η‐ε interaction.

Article Title: Population Pharmacokinetics and Probability of Target Attainment Analysis of Vancomycin Following Intermittent and Continuous Infusion in Adults with Cystic Fibrosis
Article Snippet: The PopPK analysis for vancomycin plasma concentrations was performed using a non-linear mixed-effect modeling approach using NONMEM® 7.5, ICON plc., MD, USA interfaced with Perl-speaks-NONMEM (PsN ® ) version 5.3.0 ( ) and Finch StudioTM NONMEM workbench, Enhanced Pharmacodynamics LLC, NY, USA ( ).

Article Title: Model-based translation of the PKPD-relationship for linezolid and vancomycin on methicillin-resistant Staphylococcus aureus : from in vitro time–kill experiments to a mouse pneumonia model
Article Snippet: NONMEM v7.5.0 (Icon PLC, Dublin, Ireland) was used for model fitting, and together with PsN v5.3.0, running the SIR and VPC tools for model evaluation.

Drug discovery:

Article Title: Effect of Amiodarone on Apixaban Exposure in Patients after Cardiac Surgery-A Population Pharmacokinetic Study.
Article Snippet: Aim To investigate the effect of amiodarone on apixaban pharmacokinetics in cardiac surgery patients with postoperative atrial fibrillation.. Methods Apixaban concentrations of postoperative cardiac surgery patients with or without amiodarone therapy were quantified using liquid chromatography–tandem mass spectrometry (LC–MS/MS) in clinical routine.. A population pharmacokinetic model was built using nonlinear mixed effects modeling in NONMEM® 7.5 using first-order conditional estimation with interaction.

Article Title: Population Pharmacokinetic Analysis of Enalapril and Enalaprilat in Newly Treated Children with Heart Failure: Implications for Safe Dosing of Enalapril (LENA Studies)
Article Snippet: PopPK analysis was performed by nonlinear mixed effects modelling using NONMEM ® version 7.2.0 (ICON plc, Dublin, Ireland) and Perl-speaks-NONMEM version 4.9.0 [ , ] via the graphical user interface Pirana ® version 2.9.6 (Certara, Radnor, PA, USA).

Article Title: Population pharmacokinetics and optimized dosing of cefuroxime in critically ill patients.
Article Snippet: Non-linear mixed-effect modelling was performed using NONMEM version 7.5.0 (Icon plc, Dublin, Ireland) with Pirana 2.9.7 (Certara, Princeton, NJ) as an interface using the first order conditional estimation with interaction (FOCE+I).

Article Title: Population Pharmacokinetic and Exposure-Response Analyses of Ibrutinib Combined With Bendamustine and Rituximab in Patients With Mantle Cell Lymphoma.
Article Snippet: Non- linear mixed effects modeling for the population PK analysis was performed using NONMEM version 7.3.0 (ICON plc, MD, USA) [17].

Article Title: Population Pharmacokinetic and Pharmacokinetic‐Pharmacodynamic Modeling of Serum M‐Protein Response for Modakafusp Alfa in a Phase 1/2 Study of Patients With Relapsed or Refractory Multiple Myeloma
Article Snippet: The population PK analysis for modakafusp alfa was conducted using NONMEM Version 7.4.4 (ICON plc, Dublin, Ireland) implementing the Monte Carlo importance sampling (IMP) with Laplacian conditional estimation method with η‐ε interaction.

Article Title: Population Pharmacokinetics and Probability of Target Attainment Analysis of Vancomycin Following Intermittent and Continuous Infusion in Adults with Cystic Fibrosis
Article Snippet: The PopPK analysis for vancomycin plasma concentrations was performed using a non-linear mixed-effect modeling approach using NONMEM® 7.5, ICON plc., MD, USA interfaced with Perl-speaks-NONMEM (PsN ® ) version 5.3.0 ( ) and Finch StudioTM NONMEM workbench, Enhanced Pharmacodynamics LLC, NY, USA ( ).

Article Title: Model-based translation of the PKPD-relationship for linezolid and vancomycin on methicillin-resistant Staphylococcus aureus : from in vitro time–kill experiments to a mouse pneumonia model
Article Snippet: NONMEM v7.5.0 (Icon PLC, Dublin, Ireland) was used for model fitting, and together with PsN v5.3.0, running the SIR and VPC tools for model evaluation.



Similar Products

90
CEM Corporation approximated classification expectation-maximization (cem) algorithm
Approximated Classification Expectation Maximization (Cem) Algorithm, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/approximated+classification+expectation-maximization+algorithm/classification+expectation+maximization+algorithm/pmc06527505-197-6-8
Average 90 stars, based on 1 article reviews
approximated classification expectation-maximization (cem) algorithm - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
CEM Corporation approximated classification expectation-maximization algorithm
Approximated Classification Expectation Maximization Algorithm, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/approximated+classification+expectation-maximization+algorithm/classification+expectation+maximization+algorithm/pmc06345935__41598_2018_36873_MOESM2_ESM-1352-12-11
Average 90 stars, based on 1 article reviews
approximated classification expectation-maximization algorithm - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results